Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients

NCT05807321 is registered in ClinicalTrials.gov with The California Medical Innovations Institute, Inc. as lead sponsor.

NCT NCT05807321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05807321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecobionics to Monitor and Predict Biofeedback Therapy in Dyssynergia Patients
Lead sponsor
The California Medical Innovations Institute, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
October 3, 2023
Completion date
March 31, 2027
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

constipation, dyssynergia